SMTL ID : 8u7x.2 (1 other biounit)

Crystal structure of non-receptor protein tyrosine phosphatase SHP2 in complex with inhibitor compound 24

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.06 Å

Oligo State

monomer

Ligands

1 x WAB: (3S,4S)-8-{6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]pyrido[2,3-b]pyrazin-2-yl}-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine

WAB.1: 16 residues within 4Å: Chain A: T.122, E.124, R.125, F.127, H.128, N.231, T.232, T.233, E.263, E.264, T.267, L.268, D.503, P.505, K.506, Q.509 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.127, A:E.264, A:T.267, A:L.268, A:P.505 Hydrogen bonds: A:R.125, A:F.127, A:N.231, A:T.267 Water bridges: A:R.125, A:T.232 pi-Cation interactions: A:R.125

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Elsayed, M.S.A. et al., Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors. Acs Med.Chem.Lett. (2023)

Release Date

2024-01-03

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein phosphatase non-receptor type 11

Related Entries With Identical Sequence